Pharma

Natco Pharma Ltd

NATCOPHARM · NSE · INE987B01026
₹790.7-0.15%consolidatedstandalone
Monday, 26 Oct 20262:31 pm
Sentiment17 · Extreme Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹14,549 Cr
P/E12.5
P/B1.5
EPS₹63.37
Div Yield0.8%
ROE16.9%
ROCE15.9%
ROE16.9%
1Y Return-9.19%
Avg. Volume0.5M

Price Chart

1,2091,1051,0018977931.1Cr2.3CrOct 2025Nov 2025Dec 2025Feb 2026Mar 2026Apr 2026May 2026Jul 2026

52-Week Range

₹773.6₹790.7₹1,226.8
52W Low52W High

About

Natco Pharma Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹14,549 Cr
Current Price₹790.7
52W High / Low₹1,226.8 / ₹773.6
Stock P/E12.5
Price to Book1.5
EPS (TTM)₹63.37
Dividend Yield0.8%
ROE16.9%
1Y Return-9.19%
Day Change-0.15%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹3,485 Cr₹4,078 Cr₹4,430 Cr
Expenses₹2,433 Cr₹2,617 Cr₹2,234 Cr
Operating Profit₹1,052 Cr₹1,462 Cr₹2,196 Cr
OPM %30.0%36.0%50.0%
Other Income₹295 Cr₹272 Cr₹354 Cr
Depreciation₹196 Cr₹207 Cr₹235 Cr
Interest₹46 Cr₹37 Cr₹24 Cr
Profit Before Tax₹1,104 Cr₹1,491 Cr₹2,291 Cr
Tax₹-41 Cr₹73 Cr₹408 Cr
Net Profit₹1,145 Cr₹1,418 Cr₹1,883 Cr
EPS (₹)58.372.396.1
Dividend Payout %—6%6%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹735 Cr₹739 Cr₹647 Cr₹1,363 Cr
Expenses₹549 Cr₹612 Cr₹489 Cr₹784 Cr
Operating Profit₹186 Cr₹128 Cr₹159 Cr₹579 Cr
OPM %25.0%17.0%25.0%42.0%
Depreciation₹47 Cr₹50 Cr₹46 Cr₹52 Cr
Interest₹13 Cr₹11 Cr₹10 Cr₹13 Cr
Net Profit₹206 Cr₹269 Cr₹151 Cr₹518 Cr
EPS (₹)10.513.77.726.4
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹36 Cr₹36 Cr₹36 Cr
Reserves₹9,185 Cr₹7,571 Cr₹5,817 Cr
Borrowings₹714 Cr₹279 Cr₹371 Cr
Other Liabilities₹1,139 Cr₹745 Cr₹682 Cr
Total Liabilities₹11,074 Cr₹8,631 Cr₹6,906 Cr
Assets
Fixed Assets₹2,803 Cr₹2,698 Cr₹2,491 Cr
Investments₹3,127 Cr₹474 Cr₹539 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹4,850 Cr₹5,234 Cr₹3,739 Cr
Total Assets₹11,074 Cr₹8,631 Cr₹6,906 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,768 Cr₹-1,987 Cr₹298 Cr₹79 Cr
FY25₹1,697 Cr₹-1,436 Cr₹-211 Cr₹50 Cr
FY24₹1,212 Cr₹-1,026 Cr₹-247 Cr₹-62 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd——+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-28Board Meeting Outcome for Outcome Of Fund Raising Committee Meeting Approving The Letter Of Offer For Rights IssueBSE Filing2026-08-14Natco Pharma Ltd (BOM:524816) (Q1 2027) Earnings Call Highlights: Strategic Investments and ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.